Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Oncology Researchers Awarded DHT Summer Studentships

Published: Monday, July 01, 2013
Last Updated: Monday, July 01, 2013
Bookmark and Share
Award winners named as Professor Eric Blair of University of Leeds and Professor Oliver Hanemann ofPlymouth University.

The DHT scheme, now in its second year, enables undergraduates to extend their studies over the summer period by gaining practical lab experience, using non-animal approaches, that will further our understanding of devastating diseases.
Each award is worth up to £1,440 over a maximum 8 week period, with a separate budget of up to £500 available for consumables.
Professor Blair’s student, Jonathan Carr, who is studying for a BSc in Medical Biochemistry, will extend his studies by gaining practical laboratory experience to understand whether human adenoviruses can enter, spread and migrate through a multi-cellular tumour spheroid and whether this process can be monitored in real time using live cell imaging techniques.  
Professor Hanemann’s student, Jade Lyons-Rimmer, who is studying for a BSc in Clinical Sciences, will aim to identify novel binding partners of KSR1 in human Schwann cells using a proteomics-based approach to further understand the roles of KSR1 in proliferation and apoptosis of Schwann cells.  This project offers exciting replacement potential and this non-animal approach alone will prevent approximately 190 mice being used.
Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “Our Summer Studentship award is an opportunity to inspire the next generation of research students.
“We are really encouraged by the quality and quantity of the entries we have received this year. The winners of our awards clearly demonstrated how their animal-alternative research techniques had the potential to replace the use of many animals in conventional biomedical research.

"We are confident that the projects chosen will deliver not only valuable science but whet an appetite in these students to continue this work long after they graduate."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos